Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Much Will The Cardiac AI Monitoring And Diagnostics Market Be Worth By 2029?
In recent years, the market size of cardiac AI monitoring and diagnostics has experienced exponential growth. The forecast predicts a surge from $1.71 billion in 2024 to $2.14 billion in 2025, indicating a compound annual growth rate (CAGR) of 25.6%. The considerable growth in the historical period is ascribed to factors such as an aging population, increased utilization of remote patient monitoring, augmented healthcare spending, clinical research, validation studies, and a stronger emphasis on preventive healthcare.
In the coming years, the cardiac ai monitoring and diagnostics market is anticipated to undergo significant expansion, with a prediction of a growth increase to $5.48 billion by 2029, at an impressive compound annual growth rate (CAGR) of 26.4%. This forthcoming growth within the predicted period reflects the broader adoption of wearable and IoT devices, the increasing preference for telemedicine and remote monitoring models, the integration of big data technology and predictive modelling, and emphasis on patient-focussed care and remote patient engagement, as well as improvements in healthcare infrastructures. The upcoming period is also expected to witness some key trends such as intertwining AI with wearable technology, personalized evaluations and treatment strategies, insightful analytics for potential cardiovascular events, incorporation of various data sources, and standardized interoperability and data assimilation.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13820&type=smp
What External And Internal Drivers Are Influencing The Cardiac AI Monitoring And Diagnostics Market?
The escalating rise of heart-related disorders is projected to fuel the expansion of the cardiac AI monitoring and diagnostics industry. Cardiovascular diseases (CVDs) include various afflictions related to the heart and blood vessels, such as cerebrovascular disease, coronary heart disease, rheumatic heart disease, and others. The role of cardiac AI monitoring and diagnostics is pivotal in the early detection, risk evaluation, and personalized treatment of cardiovascular diseases, leading to improved health outcomes for patients. Take for example, data released by the British Heart Foundation, a cardiovascular research charity based in the UK, in September 2024. Around 7.6 million people in the UK are battling heart and circulatory diseases, including close to 4 million men and 3.6 million women. These diseases account for roughly 27% of total fatalities in the UK, meaning over 170,000 deaths per year, or approximately 480 deaths daily, signifying a death every three minutes. Hence, the escalating occurrence of cardiovascular diseases is pushing growth in the cardiac AI monitoring and diagnostics market.
What Segmentation Insights Are Provided In The Cardiac AI Monitoring And Diagnostics Market Research?
The cardiac ai monitoring and diagnosticsmarket covered in this report is segmented –
1) By Type: Cardiac Diagnostics; Cardiac Monitoring
2) By Product: Software; Hardware
3) By Application: Ischemic Heart Diseases Or Coronary Artery Disease (CAD); Cardiac Arrhythmias; Ischemic Stroke; Other Applications
4) By End Users: Hospitals; Diagnostic Centers; Other End Users
Subsegments:
1) By Cardiac Diagnostics: ECG Analysis; Echocardiography Analysis; Cardiac Imaging; Biomarker Analysis
2) By Cardiac Monitoring: Wearable Cardiac Monitors; Remote Patient Monitoring Systems; Implantable Cardiac Devices; Continuous ECG Monitoring Systems
Which Trends Are Likely To Redefine Growth Paths In The Cardiac AI Monitoring And Diagnostics Market?
Key enterprises in the cardiac AI monitoring and diagnostics sector are dedicating their efforts to the creation of technology-driven medical devices, including artificial intelligence-equipped implantable cardiac monitors, with the aim to bolster their market stand. These AI-powered devices function continuously to monitor cardiac health. As an illustration, in May 2023, Biotronik, a cardiovascular biomedicine and technology firm based in Germany, received the approval of the BIOMONITOR IV implantable cardiac monitor (ICM) from the US Food and Drug Administration (FDA). BIOTRONIK’s pioneering, AI-based SmartECG algorithm is utilised by the BIOMONITOR IV implantable cardiac monitor (ICM), an advanced system capable of eradicating 86% of all incorrect detections while preserving 98% of authentic episodes. This groundbreaking innovation heightens detection precision for medical professionals, reducing the likelihood of false positive alerts and enabling them to rapidly and accurately diagnose specific cardiac disorders. In addition to the SmartECG technology, BIOMONITOR IV is the inaugural ICM that can differentiate between premature atrial contractions (PACs) and premature ventricular contractions (PVCs).
Who Are The Leading Companies Driving The Cardiac AI Monitoring And Diagnostics Market?
Major companies operating in the cardiac ai monitoring and diagnostics market report are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Boston Scientific Corporation, ZOLL Medical Corporation, Canon Medical Systems Corporation, Biotronik SE & Co. KG, iRhythm Technologies Inc., Tempus Labs Inc., Viz.ai Inc., HeartFlow Inc., Aidoc, Eko Devices Inc., CardioFocus Inc., Circle Cardiovascular Imaging Inc., Ultromics Limited., Cathworks, Medicalgorithmics S.A., Nanox.AI Ltd, Cardiac Insight Inc., CardioSecur GmbH, Cardionomic Inc., HeartSciences, CardioComm Solutions Inc., CardioDiagnostics Inc.
Access The Complete Report Here:
Which Geographic Regions Are Creating Strong Demand In The Cardiac AI Monitoring And Diagnostics Market?
North America was the largest region in the cardiac AI monitoring and diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac ai monitoring and diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=13820&type=smp
Browse Through More Reports Similar to the Global Cardiac AI Monitoring And Diagnostics Market 2025, By The Business Research Company
Cardiac Assist Devices And Equipment Global Market Report 2025
Cardiac Rhythm Management Crm Devices And Equipment Global Market Report 2025
Cardiac Pacemakers Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cardiac-pacemakers-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model